These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 25135367)

  • 1. Precision therapy for lymphoma--current state and future directions.
    Intlekofer AM; Younes A
    Nat Rev Clin Oncol; 2014 Oct; 11(10):585-96. PubMed ID: 25135367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview: A New Era of Cancer Genomics in Lymphoid Malignancies.
    Iida S
    Oncology; 2015; 89 Suppl 1():4-6. PubMed ID: 26551834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level.
    Chung C
    J Oncol Pharm Pract; 2020 Jun; 26(4):943-966. PubMed ID: 31964218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic Signaling Pathways and Pathway-Based Therapeutic Biomarkers in Lymphoid Malignancies.
    Sun R; Wang J; Young KH
    Crit Rev Oncog; 2017; 22(5-6):527-557. PubMed ID: 29604930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted therapy in cancer.
    Tsimberidou AM
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1113-32. PubMed ID: 26391154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to modernize the combination drug development paradigm.
    Day D; Siu LL
    Genome Med; 2016 Oct; 8(1):115. PubMed ID: 27793177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic heterogeneity in breast cancer: the road to personalized medicine?
    Baird RD; Caldas C
    BMC Med; 2013 Jun; 11():151. PubMed ID: 23800221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment.
    Crombie JL; Armand P
    Surg Oncol Clin N Am; 2020 Jan; 29(1):115-125. PubMed ID: 31757308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision and predictive medicine in urothelial cancer: are we making progress?
    Bellmunt J; Orsola A; Sonpavde G
    Eur Urol; 2015 Oct; 68(4):547-9. PubMed ID: 25935702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
    Coyne GO; Takebe N; Chen AP
    Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
    Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
    Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents.
    Inamdar AA; Goy A; Ayoub NM; Attia C; Oton L; Taruvai V; Costales M; Lin YT; Pecora A; Suh KS
    Oncotarget; 2016 Jul; 7(30):48692-48731. PubMed ID: 27119356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and possible applications of genomics in lung cancer.
    Alharbi KK
    Asian Pac J Cancer Prev; 2015; 16(5):1693-8. PubMed ID: 25773789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision Medicine and Targeted Therapies in Breast Cancer.
    Greenwalt I; Zaza N; Das S; Li BD
    Surg Oncol Clin N Am; 2020 Jan; 29(1):51-62. PubMed ID: 31757313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future Clinical Trials: Genetically Driven Trials.
    Astsaturov I
    Surg Oncol Clin N Am; 2017 Oct; 26(4):791-797. PubMed ID: 28923231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successes and limitations of targeted cancer therapy in breast cancer.
    Curigliano G; Criscitiello C
    Prog Tumor Res; 2014; 41():15-35. PubMed ID: 24727984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker-guided therapy for colorectal cancer: strength in complexity.
    Sveen A; Kopetz S; Lothe RA
    Nat Rev Clin Oncol; 2020 Jan; 17(1):11-32. PubMed ID: 31289352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Cancer: Genetics and the Role of Precision Medicine.
    Li CC; Shen Z; Bavarian R; Yang F; Bhattacharya A
    Surg Oncol Clin N Am; 2020 Jan; 29(1):127-144. PubMed ID: 31757309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized medicine approaches for colon cancer driven by genomics and systems biology: OncoTrack.
    Henderson D; Ogilvie LA; Hoyle N; Keilholz U; Lange B; Lehrach H;
    Biotechnol J; 2014 Sep; 9(9):1104-14. PubMed ID: 25074435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precision Medicine in the Treatment of Melanoma.
    Aderhold K; Wilson M; Berger AC; Levi S; Bennett J
    Surg Oncol Clin N Am; 2020 Jan; 29(1):1-13. PubMed ID: 31757306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.